Insider Transactions in Q3 2023 at Medpace Holdings, Inc. (MEDP)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
            Sep 30                          
            2023                          
           | Cornelius P. Mc Carthy Iii Director | 
              BUY
             
                Exercise of conversion of derivative security
             | Direct | 
              82
              +25.0%
           | 
              -                 
           | 
| 
            Sep 30                          
            2023                          
           | Robert O. Kraft Director | 
              BUY
             
                Exercise of conversion of derivative security
             | Direct | 
              94
              +25.0%
           | 
              -                 
           | 
| 
            Sep 30                          
            2023                          
           | Brian T Carley Director | 
              BUY
             
                Exercise of conversion of derivative security
             | Direct | 
              103
              +1.32%
           | 
              -                 
           | 
| 
            Sep 21                          
            2023                          
           | Medpace Investors, LLC > 10% Shareholder | 
              SELL
             
                Open market or private sale
             | Direct | 
              61,655
              -1.03%
           | 
              $15,043,820              
              $244.27 P/Share              
           | 
| 
            Sep 21                          
            2023                          
           | August J. Troendle CEO | 
              SELL
             
                Open market or private sale
             | Indirect | 
              61,655
              -1.03%
           | 
              $15,043,820              
              $244.27 P/Share              
           | 
| 
            Sep 20                          
            2023                          
           | Medpace Investors, LLC > 10% Shareholder | 
              SELL
             
                Open market or private sale
             | Direct | 
              65,653
              -1.09%
           | 
              $16,741,515              
              $255.48 P/Share              
           | 
| 
            Sep 20                          
            2023                          
           | August J. Troendle CEO | 
              SELL
             
                Open market or private sale
             | Indirect | 
              65,653
              -1.09%
           | 
              $16,741,515              
              $255.48 P/Share              
           | 
| 
            Sep 19                          
            2023                          
           | August J. Troendle CEO | 
              SELL
             
                Open market or private sale
             | Indirect | 
              137,379
              -2.22%
           | 
              $35,581,161              
              $259.66 P/Share              
           | 
| 
            Sep 19                          
            2023                          
           | Medpace Investors, LLC > 10% Shareholder | 
              SELL
             
                Open market or private sale
             | Direct | 
              137,379
              -2.22%
           | 
              $35,581,161              
              $259.66 P/Share              
           | 
| 
            Sep 18                          
            2023                          
           | August J. Troendle CEO | 
              SELL
             
                Open market or private sale
             | Indirect | 
              53,385
              -0.86%
           | 
              $14,627,490              
              $274.76 P/Share              
           | 
| 
            Sep 18                          
            2023                          
           | Medpace Investors, LLC > 10% Shareholder | 
              SELL
             
                Open market or private sale
             | Direct | 
              53,385
              -0.86%
           | 
              $14,627,490              
              $274.76 P/Share              
           | 
| 
            Aug 14                          
            2023                          
           | Robert O. Kraft Director | 
              SELL
             
                Open market or private sale
             | Direct | 
              13,782
              -98.65%
           | 
              $3,652,230              
              $265.67 P/Share              
           | 
| 
            Aug 14                          
            2023                          
           | Robert O. Kraft Director | 
              BUY
             
                Exercise of conversion of derivative security
             | Direct | 
              13,782
              +49.66%
           | 
              $358,332              
              $26.44 P/Share              
           | 
| 
            Jul 31                          
            2023                          
           | Kevin M. Brady CFO & Treasurer | 
              SELL
             
                Open market or private sale
             | Direct | 
              7,000
              -53.85%
           | 
              $1,785,000              
              $255.0 P/Share              
           | 
| 
            Jul 31                          
            2023                          
           | Kevin M. Brady CFO & Treasurer | 
              BUY
             
                Exercise of conversion of derivative security
             | Direct | 
              10,000
              +43.48%
           | 
              $900,000              
              $90.65 P/Share              
           | 
| 
            Jul 27                          
            2023                          
           | Stephen P Ewald General Counsel & Corp. Secy. | 
              SELL
             
                Open market or private sale
             | Direct | 
              21,850
              -59.53%
           | 
              $5,549,900              
              $254.39 P/Share              
           | 
| 
            Jul 27                          
            2023                          
           | Stephen P Ewald General Counsel & Corp. Secy. | 
              BUY
             
                Exercise of conversion of derivative security
             | Direct | 
              21,850
              +37.32%
           | 
              $2,337,950              
              $107.93 P/Share              
           |